Top 10 Key Players in the Vietnam Ataxia Market | Top Companies & Insights 2026

Top 10 Key Players in the Vietnam Ataxia Market

The Vietnam Ataxia market is shaped by established global pharmaceutical companies and prominent local players, each striving to capture market share through innovative treatment development and strong regional presence. Key players include Novartis AG, Pfizer Inc., Sanofi, GSK (GlaxoSmithKline) Vietnam, and Roche (F. Hoffmann-La Roche Ltd.).

Vietnam Ataxia Market Overview

According to 6Wresearch, the Vietnam Ataxia market is growing, due to growing awareness levels and the prevalence of neurodegenerative disorders. Ataxia is a disorder that affects motor function, and is being recognised for its impact on quality of life. The market is fuelled by the need to develop effective treatments, as well as an increasing focus on neurological health, which is gaining momentum. Furthermore, the growth of the healthcare infrastructure, along with increased clinical trials, is driving the growth of this market. Alongside, organizations are investing heavily in R&D to cater to the needs of individuals suffering from Ataxia.

Competitive Landscape

The competitive landscape in the Vietnam Ataxia Industry is characterized by multinational pharmaceutical companies that use their superior R&D capabilities to bring innovations in the treatment of neurodegenerative disorders. The multinational pharmaceutical companies are currently focused on expanding their footprint by forging strategic partnerships and conducting clinical trials in the country.

Below is a list of leading players operating in the Vietnam Ataxia Market:

1. Novartis AG

Novartis is a dominant force in neuroscience, providing advanced treatments for neurodegenerative pathways and researching innovative therapies.

2. Pfizer Inc.

Pfizer maintains a strong presence in Vietnam, focusing on a rare disease portfolio and specialized therapies for genetic conditions.

3. Sanofi

Sanofi is a key player, particularly through its specialty care division which focuses on rare genetic diseases and orphan drugs.

4. GSK (GlaxoSmithKline) Vietnam

GSK is a significant provider of neurological and supportive treatments, utilizing a robust distribution network within the public and private healthcare sectors.

5. Roche (F. Hoffmann-La Roche Ltd.)

Roche contributes to the market through its expertise in molecular diagnostics and neuroscience.

6. Imexpharm Pharmaceutical Joint Stock Company

A leading local manufacturer with EU-GMP certified facilities, providing high-quality generic solutions for central nervous system disorders.

7. DHG Pharmaceutical Joint-Stock Company

DHG produces a wide range of supportive medications used in managing the symptoms of motor-function disorders.

8. Traphaco Joint Stock Company

Traphaco is highly regarded for its innovation in modern and traditional medicine, investing heavily in R&D for neurological health.

9. Pymepharco

Specializes in high-tech generic medicines and has established strategic partnerships with international players to boost the quality of Ataxia care.

10. Mekophar Chemical Pharmaceutical Joint Stock Company

A long-standing company specializing in both prescription and non-prescription drugs, ensuring the availability of essential medicines.

Top 10 Key Players in the Vietnam Ataxia Market: FAQs